Nutex Health Reports Strong Q2 2025 Earnings with Significant Revenue and Patient Growth
Nutex Health (NUTX) reported a significant increase in revenue, patient visits, and adjusted EBITDA for the second quarter of 2025. Total revenue rose by 220% year-over-year to $244 million, driven by strong operational performance and effective management strategies.
Tickers: $NUTX